In the US, Zolinza (vorinostat systemic) is a member of the drug class histone deacetylase inhibitors and is used to treat Cutaneous T-cell Lymphoma.
US matches:
- Zolinza
Ingredient matches for Zolinza
Vorinostat
Vorinostat is reported as an ingredient of Zolinza in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment